Literature DB >> 13679067

Reactive oxygen species mediate TGF-beta1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells.

Zongpei Jiang1, Ji Yeon Seo, Hunjoo Ha, Eun Ah Lee, Yu Seun Kim, Dong Cheol Han, Soo Tack Uh, Choon Sik Park, Hi Bahl Lee.   

Abstract

Transforming growth factor-beta1 (TGF-beta1) promotes tissue fibrosis by upregulating genes encoding extracellular matrix proteins and by increasing the synthesis of plasminogen activator inhibitor-1 (PAI-1). TGF-beta1 induces cellular reactive oxygen species (ROS) and PAI-1 promoter region has binding sites for redox sensitive transcription factors. We, therefore, hypothesized that TGF-beta1-induced upregulation of PAI-1 is ROS-dependent. Using cultured glomerular mesangial cells, we confirmed that TGF-beta1 induces cellular ROS, upregulates PAI-1 mRNA and protein expression, and suppresses plasmin activity. We further demonstrated that H(2)O(2) stimulates PAI-1 expression and suppresses plasmin activity and that N-acetylcysteine effectively reverses TGF-beta1- and H(2)O(2)-induced changes in PAI-1 expression and plasmin activity. Basal as well as TGF-beta1- and H(2)O(2)-induced PAI-1 expression was upregulated by depletion of intracellular GSH. The present data demonstrate that TGF-beta1-induced PAI-1 in mesangial cells is ROS-dependent and imply that cellular ROS may be potential therapeutic targets in glomerular fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679067     DOI: 10.1016/j.bbrc.2003.08.102

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Therapeutic potential and anti-amyloidosis mechanisms of tert-butylhydroquinone for Alzheimer's disease.

Authors:  Hasina Akhter; Ashwini Katre; Ling Li; Xuebo Liu; Rui-Ming Liu
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling.

Authors:  Shuanhu Zhou; Stanislav Lechpammer; Joel S Greenberger; Julie Glowacki
Journal:  J Biol Chem       Date:  2005-04-20       Impact factor: 5.157

3.  Plasminogen activator inhibitor-1 antisense oligodeoxynucleotides abrogate mesangial fibronectin accumulation.

Authors:  Jehyun Park; Ji Yeon Seo; Hunjoo Ha
Journal:  Korean J Physiol Pharmacol       Date:  2010-12-31       Impact factor: 2.016

4.  Regulation of plasminogen activator inhibitor-1 expression in endothelial cells with exposure to metal nanoparticles.

Authors:  Min Yu; Yiqun Mo; Rong Wan; Sufan Chien; Xing Zhang; Qunwei Zhang
Journal:  Toxicol Lett       Date:  2010-02-18       Impact factor: 4.372

5.  Oxidative exposure impairs TGF-β pathway via reduction of type II receptor and SMAD3 in human skin fibroblasts.

Authors:  Tianyuan He; Taihao Quan; Yuan Shao; John J Voorhees; Gary J Fisher
Journal:  Age (Dordr)       Date:  2014-02-20

Review 6.  Oxidative and nitrosative stress and fibrogenic response.

Authors:  R Urtasun; L Conde de la Rosa; N Nieto
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

7.  Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.

Authors:  Praveen K Vayalil; Karen E Iles; Jinah Choi; Ae-Kyung Yi; Edward M Postlethwait; Rui-Ming Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-09-21       Impact factor: 5.464

Review 8.  Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

Authors:  Rui-Ming Liu
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 9.  NOX enzymes and diabetic complications.

Authors:  Tomoko Kakehi; Chihiro Yabe-Nishimura
Journal:  Semin Immunopathol       Date:  2008-05-17       Impact factor: 9.623

Review 10.  The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases.

Authors:  Hunjoo Ha; Eun Y Oh; Hi B Lee
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.